2.6. Statistical analysis

KS Katherine E. R. Smith
KP Kah-Whye Peng
JP Jose S. Pulido
AW Adam J. Weisbrod
CS Carrie A. Strand
JA Jacob B. Allred
AN Alysha N. Newsom
LZ Lianwen Zhang
NP Nandakumar Packiriswamy
TK Timothy Kottke
JT Jason M. Tonne
MM Madelyn Moore
HM Heather N. Montane
LK Lisa A. Kottschade
RM Robert R. McWilliams
AD Arkadiusz Z. Dudek
YY Yiyi Yan
AD Anastasios Dimou
SM Svetomir N. Markovic
MF Mark J. Federspiel
RV Richard G. Vile
RD Roxana S. Dronca
MB Matthew S. Block
request Request a Protocol
ask Ask a question
Favorite

The maximum tolerated dose was defined as the highest DL among those tested where at most 1 out of 6 patients developed a DLT, and the next highest DL was such that 2 of the 3 to 6 patients treated at this DL developed a DLT. Adverse events were summarized in frequency tables. Tumor responses were summarized by simple descriptive summary statistics. OS was defined as the time from registration to death due to any cause and was estimated with Kaplan-Meier (KM) curves.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A